• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-1; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-1; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Catalog Number SXPP1A401
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Scar Tissue (2060); Reaction (2414); No Code Available (3191)
Event Date 07/11/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested and the following was obtained: the patient demographic info: age, weight, bmi at the time of index procedure.The patient¿s initials are (b)(6).Female.Were cultures performed? results? no further information is available.Did the patient receive any prophylactic antibiotics pre- or intra-op? no further information is available.Other relevant patient history/concomitant medications.No further information is available.What is physician¿s opinion as to the etiology of or contributing factors to this event? at the time of emergency cesarean section, it was in the condition of chorionic amniotic inflammation, and the infection risk was high.Does the surgeon believe there was any deficiency with the ethicon device used in this procedure that caused and/or contributed to the post-operative complications? the surgeon commented that suture protrusion from the wound site by surgical site infection is occasionally occurs, and there is a high possibility that there is no causal relationship with the product.What is the patient¿s current status? the patient visits the hospital regularly.No further information will be provided.Did both the stratafix and the pds suture extrude from the wound site? only stratafix extruded.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Was there any alleged deficiency related to the pds suture that caused and/or contributed to the post-operative complications? note: event related to pds suture reported via medwatch 2210968-2019-85977.
 
Event Description
It was reported that the patient underwent caesarean section on (b)(6) 2019 and barbed suture was used on the fascia by continuous suturing when closing the wound.Two months or more post-operatively, the patient felt stiffness at the wound site.On (b)(6) 2019, when the patient visited the hospital, it was found that inflammation reaction occurred on the wound site.There was drainage from the stiff site.The barbed suture that was used for the fascia had protruded about 1 cm from the wound site.The wound site is the lower end 3 cm of the lower abdominal midline incision.The patient experienced light scarring.There was a 1 mm hole and slight redness at the center of it.The patient¿s wound was treated as an outpatient and the condition is recovering.Gentamicin and drenison tape were prescribed from another facility, shower washing at home and gentamicin application treatment.It was reported that depending on the condition, plastic surgery consultation will be considered.The surgeon opined that suture protrusion from the wound site by surgical site infection occasionally occurs, and there is a high possibility that there is no causal relationship with the product.It was reported that a contributing factor at the time of emergency cesarean section is condition of chorionic amniotic inflammation, and the infection risk was high.The patient visits the hospital regularly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SYM PDS+ UNI VIO 18IN 0 S/A CT-1
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key8920171
MDR Text Key155183419
Report Number2210968-2019-85976
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031219342
UDI-Public10705031219342
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K113004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 07/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSXPP1A401
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/29/2019
Initial Date FDA Received08/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-